Jeong A Park
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 29, 2024
High-Risk Neuroblastoma Challenges and Opportunities for Antibody-Based Cellular Immunotherapy.Natasha V Persaud, Jeong A Park, Nai Kong V Cheung
|Mar 29, 2023
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody.Jeong A Park, Madelyn Espinosa-Cotton, Hong-Fen Guo
|Jan 28, 2022
Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies.Jeong A Park, Nai-Kong V Cheung
|Sep 09, 2021
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy.Tsung-Yi Lin, Jeong A Park, Alan Long
|May 14, 2021
Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release.Jeong A Park, Brian H Santich, Hong Xu
|Mar 13, 2020
Interdomain spacing and spatial configuration drive the potency of IgG-[L]-scFv T cell bispecific antibodies.Brian H Santich, Jeong A Park, Hoa Tran
Pageof 1
